Back to Search
Start Over
Histone deacetylase 6 suppression protects from myocardial ischaemia-reperfusion injury in diabetes: insights from genetic deletion and pharmacological inhibition.
- Source :
-
Cardiovascular research [Cardiovasc Res] 2024 Oct 14; Vol. 120 (12), pp. 1369-1371. - Publication Year :
- 2024
-
Abstract
- Competing Interests: Conflict of interest: C.M.M. has received research grants to the institution from EliLilly, AstraZeneca, Roche, Amgen, Novartis, Novo Nordisk, and MSD, including speaker or consultant fees.
- Subjects :
- Animals
Mice
Mice, Knockout
Diabetes Mellitus, Experimental enzymology
Diabetes Mellitus, Experimental genetics
Diabetes Mellitus, Experimental complications
Diabetes Mellitus, Experimental metabolism
Myocardial Reperfusion Injury prevention & control
Myocardial Reperfusion Injury enzymology
Myocardial Reperfusion Injury genetics
Myocardial Reperfusion Injury pathology
Myocardial Reperfusion Injury metabolism
Histone Deacetylase Inhibitors pharmacology
Histone Deacetylase Inhibitors therapeutic use
Histone Deacetylase 6 antagonists & inhibitors
Histone Deacetylase 6 metabolism
Histone Deacetylase 6 genetics
Subjects
Details
- Language :
- English
- ISSN :
- 1755-3245
- Volume :
- 120
- Issue :
- 12
- Database :
- MEDLINE
- Journal :
- Cardiovascular research
- Publication Type :
- Editorial & Opinion
- Accession number :
- 39082188
- Full Text :
- https://doi.org/10.1093/cvr/cvae145